On Oct. 26, 2017, Eric D. Hargan, Acting Secretary of the Department of Health and Human Services, announced that, as a result of the opioid epidemic, “a public health emergency exists nationwide.” As a result, counties, states and the federal government have mounted an attack on the pharmaceutical industry.
February 01, 2018Richard S. Hartunian, Jacqueline C. Wolff and Andrew C. CaseGovernment-imposed corporate monitors — once a rare occurrence in the U.S. — are now commonplace, not only with domestic regulators, but also with regulatory agencies in various other countries, in connection with enforcement proceedings and prosecutions for criminal offenses such as anti-corruption violations and other misconduct.
February 01, 2018Jonny Frank and Simon PlattWhat They Say and Do Not Say
Part Three of a Three-Part Article
The question remains: Is the defendant in a False Claims Act matter barred from discussing the case, as are the relator and the government?
February 01, 2018Andrew W. Schilling and Megan E. WhitehillRoyal Dutch Shell and Eni Head to Trial over Nigeria Corruption Allegations
February 01, 2018ssalkinKeppel Settles Bribery Charges in the U.S., Singapore, and Brazil
February 01, 2018ljnstaffThe Second Circuit recently reversed a district court's determination that federal prosecutors and agents were not entitled to qualified immunity from plaintiffs' Bivens claims for money damages for violations of the Fourth and Fifth Amendments in procuring and executing a search warrant.
January 01, 2018Harry Sandick and Clint MorrisonIn 2017, two cases illustrated that Delaware courts continue to impose exacting pleading burdens on Caremark claims, especially when plaintiffs say that they are excused from making a demand on the board before suing derivatively.
January 01, 2018Jason J. Mendro and Jeffrey S. RosenbergDiscussion of two major rulings out of Georgia and New York.
January 01, 2018ljnstaff
This button clears the current text from the Search Input field. Submit your search query.
